Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib

被引：0

作者：

Houssam Oweini

Zaher K. Otrock

Rami A. R. Mahfouz

Ali Bazarbachi

机构：

[1] American University of Beirut Medical Center,Department of Internal Medicine

[2] American University of Beirut Medical Center,Department of Pathology and Laboratory Medicine

[3] American University of Beirut Medical Center,Bone Marrow Transplantation Program, Department of Medicine

来源：

Archives of Gynecology and Obstetrics | 2011年 / 283卷

关键词：

Chronic myeloid leukemia; Dasatinib; Pregnancy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Dasatinib is a highly potent Bcr-Abl inhibitor that is approved for the treatment of imatinib-resistant or -intolerant chronic myeloid leukemia (CML). The potential effects of dasatinib on sperm counts, sperm function, and fertility have not been studied yet. There is only one report in the medical literature of successful pregnancies while patients were taking dasatinib, thus making our case the second report. Here, we present the case of a 38-year-old man who conceived a healthy baby while on dasatinib therapy.

引用

页码：133 / 134

页数：1